Target intelligence / Profile preview

Docusate sodium (DSS)

Target
DSS
Molecular classification
Other (Small molecule drug, surfactant, laxative)
01

Overview

Docusate sodium is a synthetic anionic surfactant and small molecule used primarily as a stool softener to treat occasional constipation and facilitate bowel movements when straining is contraindicated. It acts by lowering the surface tension at the oil–water interface in stool, permitting water and fats to enter the stool and hence softening it. It may also be used as a cerumenolytic agent to hydrate and break down earwax. Docusate sodium is not a molecular target but an active pharmaceutical ingredient with physicochemical action. It is available under various brand names, including Colace and Dulcolax Stool Softener, and is also used non-medically as a surfactant in industrial and cosmetic applications. There are notable safety concerns with prolonged use or misuse, and its efficacy for constipation has been challenged in clinical studies.

Other names
Dioctyl sodium sulfosuccinateDocusateAerosol OTSodium bis(2-ethylhexyl) sulfosuccinateColace (brand)Dulcolax Stool Softener (brand)Phillips Stool Softener (brand)
02

Mechanism of action

Surfactant: reduces surface tension, allowing water and fats to mix into stool, softening it for easier passage; Emollient: acts locally to facilitate hydration of stool mass; Cerumenolytic: hydrates and breaks down earwax for removal

03

Biological functions

Emollient (stool softener)Surfactant (reduces surface tension in stool)Earwax softener (cerumenolytic)Other (non-target)
04

Disease associations

ConstipationEarwax impactionOther (not a disease target directly, but used as treatment adjunct)
05

Safety considerations

Overuse can cause dependenceGastrointestinal side effects: cramping, diarrheaSevere skin and eye irritant in concentrated form (mainly relevant to industrial use)Should not be used with mineral oil without physician instructionAcute toxicity at high doses (rat LD50 oral 1900–4200 mg/kg)Effectiveness for constipation is low compared to alternatives
06

Interacting drugs

Mineral oil

1 more in the full profile.

Beyond the preview

Go deeper on Docusate sodium (DSS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Docusate sodium (DSS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call